 | • レポートコード：MRC2-11QY09699 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は禁煙治療薬のグローバル市場について調査・分析したレポートです。種類別（NRT製品、ニコチンフリー製品）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別禁煙治療薬の競争状況、市場シェア ・世界の禁煙治療薬市場：種類別市場規模 2015年-2020年（NRT製品、ニコチンフリー製品） ・世界の禁煙治療薬市場：種類別市場規模予測 2021年-2026年（NRT製品、ニコチンフリー製品） ・世界の禁煙治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の禁煙治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の禁煙治療薬市場分析：米国、カナダ ・ヨーロッパの禁煙治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの禁煙治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の禁煙治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの禁煙治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Pfizer、Kimree Technology、Johnson & Johnson、Novartis、Dr. Reddy's Laboratories、The Harvard Drug Group、Perrigo Company、Fontem Ventures、Smoke Away ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Smoking cessation (also known as quitting smoking or simply quitting) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult.
Americas accounted for almost 42% of the market share and is expected to grow at a CAGR of around 13% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
Market Analysis and Insights: Global Smoking Cessation Drugs Market
The global Smoking Cessation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Smoking Cessation Drugs Scope and Market Size
Smoking Cessation Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Smoking Cessation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Smoking Cessation Drugs market is segmented into
NRTs Products
Nicotine-Free Products
Segment by Application, the Smoking Cessation Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Smoking Cessation Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Smoking Cessation Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Smoking Cessation Drugs Market Share Analysis
Smoking Cessation Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Smoking Cessation Drugs business, the date to enter into the Smoking Cessation Drugs market, Smoking Cessation Drugs product introduction, recent developments, etc.
The major vendors covered:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy’s Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
1 Study Coverage
1.1 Smoking Cessation Drugs Product Introduction
1.2 Market Segments
1.3 Key Smoking Cessation Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Smoking Cessation Drugs Market Size Growth Rate by Type
1.4.2 NRTs Products
1.4.3 Nicotine-Free Products
1.5 Market by Application
1.5.1 Global Smoking Cessation Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Smoking Cessation Drugs Market Size, Estimates and Forecasts
2.1.1 Global Smoking Cessation Drugs Revenue 2015-2026
2.1.2 Global Smoking Cessation Drugs Sales 2015-2026
2.2 Global Smoking Cessation Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Smoking Cessation Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Smoking Cessation Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Smoking Cessation Drugs Competitor Landscape by Players
3.1 Smoking Cessation Drugs Sales by Manufacturers
3.1.1 Smoking Cessation Drugs Sales by Manufacturers (2015-2020)
3.1.2 Smoking Cessation Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Smoking Cessation Drugs Revenue by Manufacturers
3.2.1 Smoking Cessation Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Smoking Cessation Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Smoking Cessation Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Smoking Cessation Drugs Revenue in 2019
3.2.5 Global Smoking Cessation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Smoking Cessation Drugs Price by Manufacturers
3.4 Smoking Cessation Drugs Manufacturing Base Distribution, Product Types
3.4.1 Smoking Cessation Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Smoking Cessation Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Smoking Cessation Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Smoking Cessation Drugs Market Size by Type (2015-2020)
4.1.1 Global Smoking Cessation Drugs Sales by Type (2015-2020)
4.1.2 Global Smoking Cessation Drugs Revenue by Type (2015-2020)
4.1.3 Smoking Cessation Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Smoking Cessation Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Smoking Cessation Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Smoking Cessation Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Smoking Cessation Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Smoking Cessation Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Smoking Cessation Drugs Market Size by Application (2015-2020)
5.1.1 Global Smoking Cessation Drugs Sales by Application (2015-2020)
5.1.2 Global Smoking Cessation Drugs Revenue by Application (2015-2020)
5.1.3 Smoking Cessation Drugs Price by Application (2015-2020)
5.2 Smoking Cessation Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Smoking Cessation Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Smoking Cessation Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Smoking Cessation Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Smoking Cessation Drugs by Country
6.1.1 North America Smoking Cessation Drugs Sales by Country
6.1.2 North America Smoking Cessation Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Smoking Cessation Drugs Market Facts & Figures by Type
6.3 North America Smoking Cessation Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Smoking Cessation Drugs by Country
7.1.1 Europe Smoking Cessation Drugs Sales by Country
7.1.2 Europe Smoking Cessation Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Smoking Cessation Drugs Market Facts & Figures by Type
7.3 Europe Smoking Cessation Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Smoking Cessation Drugs by Region
8.1.1 Asia Pacific Smoking Cessation Drugs Sales by Region
8.1.2 Asia Pacific Smoking Cessation Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Smoking Cessation Drugs Market Facts & Figures by Type
8.3 Asia Pacific Smoking Cessation Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Smoking Cessation Drugs by Country
9.1.1 Latin America Smoking Cessation Drugs Sales by Country
9.1.2 Latin America Smoking Cessation Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Smoking Cessation Drugs Market Facts & Figures by Type
9.3 Central & South America Smoking Cessation Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Smoking Cessation Drugs by Country
10.1.1 Middle East and Africa Smoking Cessation Drugs Sales by Country
10.1.2 Middle East and Africa Smoking Cessation Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Smoking Cessation Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Smoking Cessation Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Smoking Cessation Drugs Products Offered
11.1.5 GSK Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Smoking Cessation Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Kimree Technology
11.3.1 Kimree Technology Corporation Information
11.3.2 Kimree Technology Description and Business Overview
11.3.3 Kimree Technology Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kimree Technology Smoking Cessation Drugs Products Offered
11.3.5 Kimree Technology Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Smoking Cessation Drugs Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Smoking Cessation Drugs Products Offered
11.5.5 Novartis Related Developments
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Corporation Information
11.6.2 Dr. Reddy’s Laboratories Description and Business Overview
11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Reddy’s Laboratories Smoking Cessation Drugs Products Offered
11.6.5 Dr. Reddy’s Laboratories Related Developments
11.7 The Harvard Drug Group
11.7.1 The Harvard Drug Group Corporation Information
11.7.2 The Harvard Drug Group Description and Business Overview
11.7.3 The Harvard Drug Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 The Harvard Drug Group Smoking Cessation Drugs Products Offered
11.7.5 The Harvard Drug Group Related Developments
11.8 Perrigo Company
11.8.1 Perrigo Company Corporation Information
11.8.2 Perrigo Company Description and Business Overview
11.8.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Perrigo Company Smoking Cessation Drugs Products Offered
11.8.5 Perrigo Company Related Developments
11.9 Fontem Ventures
11.9.1 Fontem Ventures Corporation Information
11.9.2 Fontem Ventures Description and Business Overview
11.9.3 Fontem Ventures Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Fontem Ventures Smoking Cessation Drugs Products Offered
11.9.5 Fontem Ventures Related Developments
11.10 Smoke Away
11.10.1 Smoke Away Corporation Information
11.10.2 Smoke Away Description and Business Overview
11.10.3 Smoke Away Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Smoke Away Smoking Cessation Drugs Products Offered
11.10.5 Smoke Away Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Smoking Cessation Drugs Products Offered
11.1.5 GSK Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Smoking Cessation Drugs Market Estimates and Projections by Region
12.1.1 Global Smoking Cessation Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Smoking Cessation Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Smoking Cessation Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Smoking Cessation Drugs Sales Forecast (2021-2026)
12.2.2 North America: Smoking Cessation Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Smoking Cessation Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Smoking Cessation Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Smoking Cessation Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Smoking Cessation Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Smoking Cessation Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Smoking Cessation Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Smoking Cessation Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Smoking Cessation Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Smoking Cessation Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Smoking Cessation Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Smoking Cessation Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Smoking Cessation Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Smoking Cessation Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Smoking Cessation Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Smoking Cessation Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Smoking Cessation Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Smoking Cessation Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Smoking Cessation Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Smoking Cessation Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Smoking Cessation Drugs Market Segments
Table 2. Ranking of Global Top Smoking Cessation Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Smoking Cessation Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of NRTs Products
Table 5. Major Manufacturers of Nicotine-Free Products
Table 6. Global Smoking Cessation Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Smoking Cessation Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Smoking Cessation Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Smoking Cessation Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Smoking Cessation Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Smoking Cessation Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Smoking Cessation Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Smoking Cessation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Smoking Cessation Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Smoking Cessation Drugs as of 2019)
Table 15. Smoking Cessation Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Smoking Cessation Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Smoking Cessation Drugs Price (2015-2020) (USD/Unit)
Table 18. Smoking Cessation Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Smoking Cessation Drugs Product Type
Table 20. Date of International Manufacturers Enter into Smoking Cessation Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Smoking Cessation Drugs Sales Share by Type (2015-2020)
Table 24. Global Smoking Cessation Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Smoking Cessation Drugs Revenue Share by Type (2015-2020)
Table 26. Smoking Cessation Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Smoking Cessation Drugs Sales Share by Application (2015-2020)
Table 29. North America Smoking Cessation Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Smoking Cessation Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Smoking Cessation Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Smoking Cessation Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Smoking Cessation Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Smoking Cessation Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Smoking Cessation Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Smoking Cessation Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Smoking Cessation Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Smoking Cessation Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Smoking Cessation Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Smoking Cessation Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Smoking Cessation Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Smoking Cessation Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Smoking Cessation Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Smoking Cessation Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Smoking Cessation Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Smoking Cessation Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Smoking Cessation Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Smoking Cessation Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Smoking Cessation Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Smoking Cessation Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Table 69. GSK Corporation Information
Table 70. GSK Description and Major Businesses
Table 71. GSK Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GSK Product
Table 73. GSK Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Kimree Technology Corporation Information
Table 80. Kimree Technology Description and Major Businesses
Table 81. Kimree Technology Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Kimree Technology Product
Table 83. Kimree Technology Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Dr. Reddy's Laboratories Corporation Information
Table 95. Dr. Reddy's Laboratories Description and Major Businesses
Table 96. Dr. Reddy's Laboratories Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Dr. Reddy's Laboratories Product
Table 98. Dr. Reddy's Laboratories Recent Development
Table 99. The Harvard Drug Group Corporation Information
Table 100. The Harvard Drug Group Description and Major Businesses
Table 101. The Harvard Drug Group Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. The Harvard Drug Group Product
Table 103. The Harvard Drug Group Recent Development
Table 104. Perrigo Company Corporation Information
Table 105. Perrigo Company Description and Major Businesses
Table 106. Perrigo Company Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Perrigo Company Product
Table 108. Perrigo Company Recent Development
Table 109. Fontem Ventures Corporation Information
Table 110. Fontem Ventures Description and Major Businesses
Table 111. Fontem Ventures Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Fontem Ventures Product
Table 113. Fontem Ventures Recent Development
Table 114. Smoke Away Corporation Information
Table 115. Smoke Away Description and Major Businesses
Table 116. Smoke Away Smoking Cessation Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Smoke Away Product
Table 118. Smoke Away Recent Development
Table 119. Global Smoking Cessation Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Smoking Cessation Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Smoking Cessation Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Smoking Cessation Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Smoking Cessation Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Smoking Cessation Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Smoking Cessation Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Smoking Cessation Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Smoking Cessation Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Smoking Cessation Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Smoking Cessation Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Smoking Cessation Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Smoking Cessation Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Smoking Cessation Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Smoking Cessation Drugs Players
Table 137. Smoking Cessation Drugs Customers List
Table 138. Smoking Cessation Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Smoking Cessation Drugs Product Picture
Figure 2. Global Smoking Cessation Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. NRTs Products Product Picture
Figure 4. Nicotine-Free Products Product Picture
Figure 5. Global Smoking Cessation Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Smoking Cessation Drugs Report Years Considered
Figure 10. Global Smoking Cessation Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Smoking Cessation Drugs Sales 2015-2026 (K Units)
Figure 12. Global Smoking Cessation Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Smoking Cessation Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Smoking Cessation Drugs Sales Market Share by Region in 2019
Figure 15. Global Smoking Cessation Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Smoking Cessation Drugs Revenue Market Share by Region in 2019
Figure 17. Global Smoking Cessation Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Smoking Cessation Drugs Revenue in 2019
Figure 19. Smoking Cessation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Smoking Cessation Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Smoking Cessation Drugs Sales Market Share by Type in 2019
Figure 22. Global Smoking Cessation Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Smoking Cessation Drugs Revenue Market Share by Type in 2019
Figure 24. Global Smoking Cessation Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Smoking Cessation Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Smoking Cessation Drugs Sales Market Share by Application in 2019
Figure 27. Global Smoking Cessation Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Smoking Cessation Drugs Revenue Market Share by Application in 2019
Figure 29. North America Smoking Cessation Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Smoking Cessation Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Smoking Cessation Drugs Sales Market Share by Country in 2019
Figure 32. North America Smoking Cessation Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Smoking Cessation Drugs Market Share by Type in 2019
Figure 38. North America Smoking Cessation Drugs Market Share by Application in 2019
Figure 39. Europe Smoking Cessation Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Smoking Cessation Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Smoking Cessation Drugs Sales Market Share by Country in 2019
Figure 42. Europe Smoking Cessation Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Smoking Cessation Drugs Market Share by Type in 2019
Figure 54. Europe Smoking Cessation Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Smoking Cessation Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Smoking Cessation Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Smoking Cessation Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Smoking Cessation Drugs Revenue Market Share by Region in 2019
Figure 59. China Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Smoking Cessation Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Smoking Cessation Drugs Market Share by Application in 2019
Figure 83. Latin America Smoking Cessation Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Smoking Cessation Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Smoking Cessation Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Smoking Cessation Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Smoking Cessation Drugs Market Share by Type in 2019
Figure 94. Latin America Smoking Cessation Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Smoking Cessation Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Smoking Cessation Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Smoking Cessation Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Smoking Cessation Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Smoking Cessation Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Smoking Cessation Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Smoking Cessation Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Smoking Cessation Drugs Market Share by Application in 2019
Figure 107. North America Smoking Cessation Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Smoking Cessation Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Smoking Cessation Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Smoking Cessation Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Smoking Cessation Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Smoking Cessation Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Smoking Cessation Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Smoking Cessation Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Smoking Cessation Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Smoking Cessation Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
禁煙及びニコチン中毒解消製品の世界市場（～2026年） Market Analysis and Insights: Global Smoking Cessation and Nicotine De-Addiction Products Market The global Smoking Cessation and Nicotine De-Addiction Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Smoking C…- 禁煙製品の世界市場（～2026年） Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adv…
- 禁煙補助製品の世界市場（～2026年） Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking. Amongst NRT products, NRT Gums has the largest share in the market. Amongst prescription products, inhalers, and sprays have the largest market. …
- 禁煙・脱ニコチン依存症の世界市場（～2026年） Market Analysis and Insights: Global Cessation and Nicotine De-Addiction Market The global Cessation and Nicotine De-Addiction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cessation and Nicotine De-Addiction Scope a…
- 喫煙およびその他タバコ製品の世界市場（～2026年） Smoking and Other Tobacco products market includes establishments producing loose tobacco such as chewing tobacco, dissolvable tobacco and, which is used in pipes, roll-your-own (ROY) cigarettes, make-your-own (MOY) cigarettes and other tobacco products. Flavored tobacco is becoming a rising trend i…